Zhejiang Jingxin Pharmaceutical Co Ltd (002020) — Capital Reinvestment Ratio
Zhejiang Jingxin Pharmaceutical Co Ltd (002020) has a Capital Reinvestment Ratio of 0.16x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥227.64 Million) in capital expenditures (CN¥35.55 Million). See how much free cash does Zhejiang Jingxin Pharmaceutical Co Ltd generate to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Zhejiang Jingxin Pharmaceutical Co Ltd Capital Reinvestment Ratio (2002–2025)
This chart tracks Zhejiang Jingxin Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 22 annual periods.
Annual Capital Reinvestment Ratio for Zhejiang Jingxin Pharmaceutical Co Ltd (2002–2025)
Year-by-year Capital Reinvestment Ratio for Zhejiang Jingxin Pharmaceutical Co Ltd from 2002 to 2025. For live market cap and broader valuation context, see 002020 market cap.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.26x | CN¥781.35 Million | CN¥202.85 Million | ▼ -24.8% |
| 2024 | 0.35x | CN¥726.16 Million | CN¥250.65 Million | ▼ -45.2% |
| 2023 | 0.63x | CN¥824.69 Million | CN¥519.51 Million | ▲ +4.6% |
| 2022 | 0.60x | CN¥855.78 Million | CN¥515.57 Million | ▼ -45.6% |
| 2021 | 1.11x | CN¥365.02 Million | CN¥404.43 Million | ▲ +70.2% |
| 2020 | 0.65x | CN¥513.21 Million | CN¥334.00 Million | ▲ +3.3% |
| 2019 | 0.63x | CN¥535.30 Million | CN¥337.33 Million | ▲ +36.2% |
| 2018 | 0.46x | CN¥523.40 Million | CN¥242.19 Million | ▲ +58.8% |
| 2017 | 0.29x | CN¥385.01 Million | CN¥112.19 Million | ▼ -22.7% |
| 2016 | 0.38x | CN¥252.69 Million | CN¥95.26 Million | ▼ -52.3% |
| 2015 | 0.79x | CN¥144.69 Million | CN¥114.31 Million | ▲ +75.5% |
| 2014 | 0.45x | CN¥210.49 Million | CN¥94.75 Million | ▼ -53.8% |
| 2013 | 0.98x | CN¥111.03 Million | CN¥108.28 Million | ▼ -29.6% |
| 2012 | 1.39x | CN¥60.28 Million | CN¥83.51 Million | ▲ +33.8% |
| 2011 | 1.04x | CN¥69.41 Million | CN¥71.86 Million | ▼ -60.4% |
| 2010 | 2.62x | CN¥59.55 Million | CN¥155.87 Million | ▲ +1655.7% |
| 2009 | 0.15x | CN¥135.38 Million | CN¥20.18 Million | ▼ -89.8% |
| 2008 | 1.46x | CN¥29.98 Million | CN¥43.81 Million | ▼ -32.9% |
| 2005 | 2.18x | CN¥61.82 Million | CN¥134.67 Million | ▼ -85.7% |
| 2004 | 15.26x | CN¥6.43 Million | CN¥98.11 Million | ▲ +889.6% |
| 2003 | 1.54x | CN¥46.18 Million | CN¥71.19 Million | ▲ +46.8% |
| 2002 | 1.05x | CN¥45.50 Million | CN¥47.79 Million | — |